Research Library
Myostatin HMP (GDF8) research
6 articles to explore, with links to 8 original sources.
New to this topic? Start with the Myostatin (GDF8) guide.
About Myostatin HMP (GDF8)
Myostatin, or GDF8, is a TGF-beta-family signaling protein used in ligand and receptor research. The “HMP” designation remains unresolved and should not be assumed to identify a myostatin inhibitor.
Understand the science
How the precursor, latent complex and active signal differ
GDF8 is the larger protein myostatin, encoded by the human MSTN gene. “HMP” by itself leaves the exact form of GDF8 uncertain. An older laboratory paper helps explain the practical difference between a protein precursor, a latent complex and an active signal.
2 sources (2018, 2026)
Explore study findings
What FDA approved when it approved a myostatin-targeting antibody
GDF8, also called myostatin, is a larger signaling protein. The catalog label “Myostatin HMP (GDF8)” points to that protein family, while “HMP” alone leaves the molecular form uncertain.
2 sources (2025, 2026)
What lean mass preservation meant in the EMBRAZE trial
GDF8, or myostatin, is a larger protein signal that restrains muscle growth. The catalog shorthand “HMP” leaves its exact form unclear.
2 sources (2026)
What the COURAGE abstract says about starting lean mass
GDF8, or myostatin, is a larger protein signal that helps limit skeletal muscle growth. “HMP” on a catalog label leaves the GDF8 form unspecified.
1 source (2026)
Check methods and identity
What a myostatin propeptide label can establish
GDF8 is the larger protein myostatin. One part of the myostatin precursor is called the propeptide or prodomain.
1 source (2022)
Why a blood test must distinguish GDF8 from GDF11
Myostatin, called GDF8, is a larger protein signal with a close relative called GDF11. The “HMP” catalog shorthand does not specify the exact form of myostatin. An older human study from 2016 helps illustrate a related problem in research.
1 source (2016)
